Warning: The NCBI web site requires JavaScript to function. more...
An official website of the United States government
The .gov means it's official. Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you're on a federal government site.
The site is secure. The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.
Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GEO DataSets Profile neighbors
TBC1D19 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GEO DataSets Gene Profile neighbors Chromosome neighbors Homologene neighbors
NPAS3 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
KCNJ15 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
LACRT - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
CASC2 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GEO DataSets Gene Profile neighbors Chromosome neighbors
TAS1R1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
TFCP2 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
B3GALT5 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
PTCH1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
LINC01393 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
RAB11FIP2 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
ECRP - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
WIPF3 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
CYP19A1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
LBP - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
KRT4 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
TH2LCRR - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
Filters: Manage Filters
Your browsing activity is empty.
Activity recording is turned off.
Turn recording back on